FinTechFunding

Curebase: Raises $40M in Series B Funding

Curebase Raises $40M in Series B Funding

  • Curebase, a San Francisco, CA-based technology-driven clinical trial startup, raised $40m in Series B funding
  • The round was led by Industry Ventures, with participation from Acrew Capital, World Innovation Lab and Positive Sum, Gaingels, GGV Capital, Bold Capital and Xfund
  • The round also included a strategic investment by global biopharmaceutical company Gilead Sciences
  • The company, which has raised a total of $59m, intends to use the funds to continue development of its solutions
  • The company provides decentralized clinical trials (DCTs) and patient-centric clinical trial software
  • The company has now run over 50 studies to date, with 300-400% growth year over year
Previous article
Lumos: Raises Over $30M in Funding
Next article
Valia Ventures: Closes Fund II, at $50M
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...